Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Microbiota‐Driven Activation of Intrahepatic B Cells Aggravates NASH Through Innate and Adaptive Signaling
Fanta Barrow, Saad Khan, Gavin Fredrickson, et al.
Hepatology (2021) Vol. 74, Iss. 2, pp. 704-722
Open Access | Times Cited: 145

Showing 1-25 of 145 citing articles:

Aging and aging-related diseases: from molecular mechanisms to interventions and treatments
Jun Guo, Xiuqing Huang, Lin Dou, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 700
Immune cell-mediated features of non-alcoholic steatohepatitis
Thierry Huby, Emmanuel L. Gautier
Nature reviews. Immunology (2021) Vol. 22, Iss. 7, pp. 429-443
Open Access | Times Cited: 382
Hepatic inflammatory responses in liver fibrosis
Linda Hammerich, Frank Tacke
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 10, pp. 633-646
Closed Access | Times Cited: 311
Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease – novel insights into cellular communication circuits
Moritz Peiseler, Robert F. Schwabe, Jochen Hampe, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 4, pp. 1136-1160
Open Access | Times Cited: 303
The Role of Gut–Liver Axis in Gut Microbiome Dysbiosis Associated NAFLD and NAFLD-HCC
Qian Song, Xiang Zhang
Biomedicines (2022) Vol. 10, Iss. 3, pp. 524-524
Open Access | Times Cited: 88
Understanding the cellular interactome of non-alcoholic fatty liver disease
Sebastian Wallace, Frank Tacke, Robert F. Schwabe, et al.
JHEP Reports (2022) Vol. 4, Iss. 8, pp. 100524-100524
Open Access | Times Cited: 83
Liver fibrosis in NAFLD/NASH: from pathophysiology towards diagnostic and therapeutic strategies
Maurizio Parola, Massimo Pinzani
Molecular Aspects of Medicine (2023) Vol. 95, pp. 101231-101231
Open Access | Times Cited: 66
Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH)
Shuang Wang, Scott L. Friedman
Science Translational Medicine (2023) Vol. 15, Iss. 716
Open Access | Times Cited: 55
Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signalling
Elena Kotsiliti, Valentina Leone, Svenja Schuehle, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 2, pp. 296-313
Open Access | Times Cited: 50
Metabolic regulation of the immune system in health and diseases: mechanisms and interventions
Tengyue Hu, Changhai Liu, Min Lei, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 29
The “Domino effect” in MASLD: The inflammatory cascade of steatohepatitis
Karlo Mladenić, Maja Lenartić, Sonja Marinović, et al.
European Journal of Immunology (2024) Vol. 54, Iss. 4
Open Access | Times Cited: 18
Intestinal dysbiosis in nonalcoholic fatty liver disease (NAFLD): focusing on the gut–liver axis
Hui Han, Yi Jiang, Mengyu Wang, et al.
Critical Reviews in Food Science and Nutrition (2021) Vol. 63, Iss. 12, pp. 1689-1706
Closed Access | Times Cited: 90
The Emerging Role of B Cells in the Pathogenesis of NAFLD
Fanta Barrow, Saad Khan, Haiguang Wang, et al.
Hepatology (2021) Vol. 74, Iss. 4, pp. 2277-2286
Open Access | Times Cited: 79
CD4+ T cell activation and inflammation in NASH-related fibrosis
Yunfeng Zhou, Haibo Zhang, Yao Yao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 64
Exercise of high intensity ameliorates hepatic inflammation and the progression of NASH
Gavin Fredrickson, Fanta Barrow, Katrina Dietsche, et al.
Molecular Metabolism (2021) Vol. 53, pp. 101270-101270
Open Access | Times Cited: 56
Hepatic Stellate Cell-Immune Interactions in NASH
James K. Carter, Scott L. Friedman
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 53
T cells: Friends and foes in NASH pathogenesis and hepatocarcinogenesis
Pierluigi Ramadori, Shing Kam, Mathias Heikenwälder
Hepatology (2022) Vol. 75, Iss. 4, pp. 1038-1049
Closed Access | Times Cited: 46
Treating inflammation to combat non-alcoholic fatty liver disease
Leke Wiering, Frank Tacke
Journal of Endocrinology (2022) Vol. 256, Iss. 1
Open Access | Times Cited: 44
Major roles of kupffer cells and macrophages in NAFLD development
Soo-Jeung Park, Josefina Garcia Diaz, Eugene Um, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 39
Mesenchymal stem cells alleviate mouse liver fibrosis by inhibiting pathogenic function of intrahepatic B cells
Xudong Feng, Bing Feng, Jiahang Zhou, et al.
Hepatology (2024)
Open Access | Times Cited: 12
Comprehensive profiling of lipid metabolic reprogramming expands precision medicine for hepatocellular carcinoma
Qingbin Liu, Xiangyu Zhang, Jingjing Qi, et al.
Hepatology (2024)
Open Access | Times Cited: 11
Immunomodulation in non-alcoholic fatty liver disease: exploring mechanisms and applications
Ziwei Guo, Qinjuan Wu, Pengfei Xie, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Emerging Roles of T Cells in the Pathogenesis of Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma
Petra Hirsova, Adebowale O. Bamidele, Haiguang Wang, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 54
The role of the immune system in the pathogenesis of NAFLD and potential therapeutic impacts of mesenchymal stem cell-derived extracellular vesicles
Zahra Moayedfard, Farnaz Sani, Ali Alizadeh, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 34
Immune–metabolic interactions in homeostasis and the progression to NASH
Joanne A. Hoogerland, Bart Staels, David Dombrowicz
Trends in Endocrinology and Metabolism (2022) Vol. 33, Iss. 10, pp. 690-709
Open Access | Times Cited: 34
Page 1 - Next Page

Scroll to top